David Wayne Robinson
CIK: 0002107335
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OCUL
OCULAR THERAPEUTIX, INC
Officer
Discretionary Trading P&L
Holdings
About Robinson David Wayne
Robinson David Wayne (SEC CIK 0002107335) files insider reports with the SEC as Global CCO of OCULAR THERAPEUTIX, INC (OCUL).
Signal8 holds 2 ownership filings by Robinson David Wayne (1 Form 3, 1 Form 4), filed on Jan 26, 2026. Those filings report 1 transaction, the latest on Jan 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Robinson David Wayne's filings is in BEDFORD, MA.
Recent filings by Robinson David Wayne
- Jan 21, 2026: Grant or award of OCUL shares (Form 4, code A).
Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)
- Anderman Todd, Chief Legal Officer
- Kaiser Peter, Chief Development Officer
- Heier Jeffrey S., Chief Scientific Officer
- Notman Donald, Chief Operating Officer
- Nayak Sanjay, Chief Strategy Officer
- Dugel Pravin